Abstract: Annuloplasty prosthesis device (1), which is suitable for remodeling a native annulus (2), comprises a body having the shape of at least one ring portion defining a longitudinal direction, coinciding with or locally parallel to the longitudinal development direction of said body; said portion (5) being opposite to said first arcuate section (4), and the body comprises a first arcuate section (4) and at least a second segment (5); said first arcuate section (4) is flexible in a first direction, locally transverse to the longitudinal direction, so as to be deformable under flexion along said first direction; said first arcuate section (4) defines a plane of storage substantially parallel both to the longitudinal direction and to the first direction; said at least a second section (5) is rigid under flexion in said plane of storage (XY); said second section (5) is flexible in a second direction (ZZ), transverse to the plane of storage, so as to be deformable under flexion along said second direction.

Abstract: The present invention refers to a method for the production of activated CD3-CD56+ NK cells, activated CD3-CD56 NK+ cells obtainable with the method, their use, in particular for the treatment of a tumor, preferably a hepatocellular carcinoma (HCC), for use in the treatment and/or prevention of an HCV infection, for use in the treatment and/or prevention of a post-liver transplant HCV reinfection, or for use for prevention of a post-liver transplant HCC recurrence. The invention also concerns pharmaceutical compositions including the activated CD3-CD56+ NK cells.

Abstract: A construct comprising a dermal extracellular matrix gel, polymer fibers, and microparticles containing a nitro oleic acid agent.

Abstract: Disclosed mechanical stimulator systems can maintain the sterility of biological samples within a multi-well plate while mechanically stimulating the samples. The systems disclosed herein allow for the individual activation by mechanical compression of a high number of samples at the same time, while maintaining sterility of the samples. The well plates, guides, actuations pistons, and other components of the disclosed systems can be configured to be contained in or adjacent to an incubator that can control properties such as gas levels and temperature while at the same time allowing for the mechanical actuation of the biological samples.

Abstract: A method for calculating the risk of aortic rupture or dissection of an individual with an ascending thoracic aortic aneurysm, ATAA, is disclosed. The method includes the steps of obtaining a first data set linked to the clinical and/or demographic characteristics of the individual, obtaining a second data set linked to the biochemical characteristics of a biological sample of the individual, obtaining a third data set linked to the morphological and functional characteristics of the aorta and processing the third data set to obtain a fourth data set by computational modelling, integrating the first data set, the second data set, the third data set and the fourth data set in a predictive model to obtain a risk index (i) of aortic rupture or dissection, wherein the second data set includes expression values of at least one biomarker.

Abstract: The present invention refers to a method for the production of activated CD3-CD56+ NK cells, activated CD3-CD56 NK+ cells obtainable with the method, their use, in particular for the treatment of a tumor, preferably a hepatocellular carcinoma (HCC), for use in the treatment and/or prevention of an HCV infection, for use in the treatment and/or prevention of a post-liver transplant HCV reinfection, or for use for prevention of a post-liver transplant HCC recurrence. The invention also concerns pharmaceutical compositions including the activated CD3-CD56+ NK cells.